( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
61480
55610
49610
44100.19
Total Expenditure
69300
63590
59150
53717.87
PBIDT (Excl OI)
-7820
-7980
-9540
-9617.68
Other Income
960
590
870
1206.94
Operating Profit
-6860
-7390
-8670
-8410.74
Exceptional Items
-100
NA
0.00
0.00
PBDT
-7510
-7870
-9080
-8732.27
Depreciation
3130
3040
2880
2057.3
Profit Before Tax
-10640
-10910
-11960
-10789.57
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-10640
-10910
-11960
-10789.57
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-10640
-10910
-11960
-10789.57
Minority Interest
NA
NA
NA
NA
Shares of Associates
-10
-10
-10
-22.25
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-10650
-10920
-11970
-10811.82
Equity Capital
2600
2320
2300
2286.48
Calculated EPS
-4.09
-4.70
-5.20
-4.72
Calculated EPS (Annualised)
-16.38
-18.82
-20.81
-18.91
No of Public Share Holdings
2760313555
2493646892
2493646892
2286480881
% of Public Share Holdings
100
100
100
100
PBIDTM% (Excl OI)
-12.71
-14.34
-19.22
-21.80
PBIDTM%
-11.15
-13.28
-17.47
-19.07
PBDTM%
-12.21
-14.15
-18.30
-19.80
PBTM%
-17.30
-19.61
-24.10
-24.46
PATM%
-17.30
-19.61
-24.10
-24.46